Company Quick10K Filing
BioScrip
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 130 $301
10-Q 2019-11-06 Quarter: 2019-09-30
10-Q 2019-07-31 Quarter: 2019-06-30
10-Q 2019-05-03 Quarter: 2019-03-31
10-K 2019-03-15 Annual: 2018-12-31
10-Q 2018-11-06 Quarter: 2018-09-30
10-Q 2018-08-07 Quarter: 2018-06-30
10-Q 2018-05-10 Quarter: 2018-03-31
10-K 2018-03-26 Annual: 2017-12-31
10-Q 2017-11-02 Quarter: 2017-09-30
10-Q 2017-08-08 Quarter: 2017-06-30
10-Q 2017-05-04 Quarter: 2017-03-31
10-K 2017-03-07 Annual: 2016-12-31
10-Q 2016-11-08 Quarter: 2016-09-30
10-Q 2016-08-08 Quarter: 2016-06-30
10-Q 2016-05-06 Quarter: 2016-03-31
10-K 2016-03-03 Annual: 2015-12-31
10-Q 2015-11-04 Quarter: 2015-09-30
10-Q 2015-08-10 Quarter: 2015-06-30
10-Q 2015-05-08 Quarter: 2015-03-31
10-K 2015-03-02 Annual: 2014-12-31
10-Q 2014-11-07 Quarter: 2014-09-30
10-Q 2014-08-11 Quarter: 2014-06-30
10-Q 2014-05-12 Quarter: 2014-03-31
10-K 2014-03-03 Annual: 2013-12-31
10-Q 2013-11-12 Quarter: 2013-09-30
10-Q 2013-08-08 Quarter: 2013-06-30
10-Q 2013-05-09 Quarter: 2013-03-31
10-K 2013-03-15 Annual: 2012-12-31
10-Q 2012-11-09 Quarter: 2012-09-30
10-Q 2012-08-09 Quarter: 2012-06-30
10-Q 2012-05-10 Quarter: 2012-03-31
10-K 2012-03-14 Annual: 2011-12-31
10-Q 2011-11-09 Quarter: 2011-09-30
10-Q 2011-08-09 Quarter: 2011-06-30
10-Q 2011-05-05 Quarter: 2011-03-31
10-K 2011-03-16 Annual: 2010-12-31
10-Q 2010-11-03 Quarter: 2010-09-30
10-Q 2010-08-03 Quarter: 2010-06-30
10-Q 2010-05-05 Quarter: 2010-03-31
10-K 2010-03-02 Annual: 2009-12-31
8-K 2020-02-03 Shareholder Rights, Amend Bylaw, Other Events, Exhibits
8-K 2020-01-13 Regulation FD, Exhibits
8-K 2019-12-20 Other Events, Exhibits
8-K 2019-12-03 Regulation FD, Exhibits
8-K 2019-11-18 Enter Agreement, Exhibits
8-K 2019-11-06 Earnings, Exhibits
8-K 2019-08-07 Other Events, Exhibits
8-K 2019-08-06 Earnings, Officers, Other Events, Exhibits
8-K 2019-08-05 Enter Agreement, Leave Agreement, M&A, Off-BS Arrangement, Sale of Shares, Shareholder Rights, Control, Amend Bylaw, Exhibits
8-K 2019-08-02 Shareholder Vote, Other Events, Exhibits
8-K 2019-07-30 Earnings, Exhibits
8-K 2019-07-24 Other Events
8-K 2019-06-13 Other Events, Exhibits
8-K 2019-06-11 Shareholder Vote
8-K 2019-05-02 Earnings, Exhibits
8-K 2019-04-23 Other Events, Exhibits
8-K 2019-03-18 Officers
8-K 2019-03-15 Earnings, Other Events, Exhibits
8-K 2019-03-14 Enter Agreement, Off-BS Arrangement, Sale of Shares, Other Events, Exhibits
8-K 2018-11-06 Earnings, Other Events, Exhibits
8-K 2018-11-01 Regulation FD, Exhibits
8-K 2018-10-19 Officers, Regulation FD, Exhibits
8-K 2018-08-07 Earnings, Other Events, Exhibits
8-K 2018-05-29 Officers
8-K 2018-05-14 Officers
8-K 2018-05-10
8-K 2018-05-03 Shareholder Vote
8-K 2018-03-08 Earnings, Other Events, Exhibits
8-K 2018-02-27 Officers
8-K 2018-02-13 Officers

BioScrip Financials

BIOS Metrics, Comps, Filings

Annual | Quarterly

Business

BioScrip, Inc. ("BioScrip", "we", "us", "our" or the "Company") is a national provider of infusion and home care management solutions. We partner with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. We operate with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, we aim to provide cost-effective care that is driven by clinical excellence, customer service and values that promote positive outcomes and an enhanced quality of life for those whom we serve.

Our platform provides nationwide service capabilities and the ability to deliver clinical management services that offer patients a high-touch, community-based and home-based care environment. Our core services are provided in coordination with, and under the direction of, the patient's physician. Our multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to each patient's specific needs. Whether in the home, physician office, ambulatory infusion center, skilled nursing facility or other alternate sites of care, we provide products, services and condition-specific clinical management programs tailored to improve the care of individuals with complex health conditions such as gastrointestinal abnormalities, infectious diseases, cancer, multiple sclerosis, organ and blood cell transplants, bleeding disorders, immune deficiencies and heart failure.

We were incorporated in Delaware in 1996 as MIM Corporation, with our primary business and operations at the time consisting of pharmacy benefit management services.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
CVS (CVS) 71,271,480 32% 11.6 2% 218,904,000 157,305,000 226,770,000 72,447,000 4,334,000 11,702,000 135,768,480
Walgreens Boots (WBA) 49,162,080 22% 6.9 7% 68,586,000 43,814,000 136,354,000 30,423,000 4,828,000 8,710,000 60,251,080
Chemed (CHE) 5,769,171 31% 20.5 18% 1,094,072 475,503 1,837,277 573,322 200,973 285,787 5,850,848
Teladoc (TDOC) 4,518,918 67% -68.7 -7% 1,565,344 562,704 492,552 332,046 -107,617 -59,335 4,078,475
Amedisys (AMED) 3,941,092 22.8 10% 1,205,862 642,920 0 0 124,661 184,758 4,205,290
US Physical Therapy (USPH) 1,538,040 23% 20.4 10% 557,010 192,897 473,075 109,438 54,462 77,103 1,570,187
Addus HomeCare (ADUS) 1,001,296 27% 26.9 5% 408,684 119,343 566,246 152,695 18,594 36,520 983,690
Civitas Solutions (CIVI) 636,263 20% 8.1 1% 1,099,547 926,657 1,613,415 326,712 11,879 158,200 1,277,381
Concord Medical Services Holdings (CCM) 476,453 0% 4,585,394 2,311,513 0 0 0 0 191,315
Diplomat Pharmacy (DPLO) 447,714 6% -2.7 -36% 1,315,110 1,015,649 5,278,394 339,161 -471,619 -337,170 900,693
Rite Aid (RAD) 370,909 21% 18.6 -6% 10,529,689 9,494,472 21,623,656 4,634,326 -602,903 203,459 3,785,172
PetMed Express (PETS) 320,681 32% 6.0 21% 144,837 21,194 276,017 87,221 30,502 39,740 237,283
Pfenex (PFNX) 303,900 74% -9.5 -45% 64,122 12,310 20,094 14,822 -28,775 -27,536 262,079
BioScrip (BIOS) 301,453 34% -19.3 -8% 600,577 675,789 735,003 250,350 -49,485 -41,947 808,004
Molecular Templates (MTEM) 299,852 0% -10.5 -21% 131,147 41,887 23,891 0 -27,199 -26,920 283,157
Optinose (OPTN) 299,131 82% -2.3 -65% 166,572 98,100 16,078 13,214 -107,755 -97,284 228,022
LHC Group (LHCG) 3,569 37% -0.2 5% 2,029,855 566,341 2,037,312 743,725 103,628 154,422 -23,168
AdaptHealth (AHCO)
111 (YI)

Balance Sheet ($'000)2009-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash0062,1011,00174015,5779,56939,45718,860
Accounts Receivable129,103187,301114,864
Inventory51,25656,74534,03434,34137,21542,98336,16538,04426,689
PP&E15,45429,44423,72184,24238,17131,93932,53526,97328,788
Assets287,220677,102642,376936,858824,713546,505607,740603,092583,938
Accounts Payable74,53579,15534,43864,34290,03265,07759,13465,96367,025
Long-Term Debt293,459225,426375,323418,408433,984467,716480,588518,777
Liabilities131,427461,823348,967582,275607,908564,465567,301605,765634,653
Stockholders' Equity155,793215,279293,409354,583216,805-80,878-31,563-84,752-144,004
Income Statement ($'000)2009-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue1,329,5251,818,026708,903
Cost of Revenue1,171,703104,776112,406104,22677,570721,308669,958547,948465,865
Gross Profit157,822312,303224,960271,814261,066260,915265,631269,242243,038
R&D
SG&A36,26442,52439,22539,62547,264
Tax-40,5531,323-4,4392,5381,651114-372-4,130568
Net Income54,0997,87264,707-69,654-147,468-299,707-41,506-64,196-51,693
Cash Flow ($'000)2009-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating22,74526,96949,862-38,505-24,645-64,742-35,2035,630-20,003
Cash Investing-5,739-9,907-67,619-302,370-13,43113,021-72,981-13,630-13,515
Cash Financing-17,006-17,062-58,663295,823-13,10266,558109,74244,2818,072